ACEMID: revolutionising early detection and the fight against melanoma | UQ
The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) is revolutionising melanoma screening through a globally unique research program uniting world-leading expertise across dermatology, behavioural science, epidemiology, health economics, statistics, AI, data science, genetics, and pathology.
Established in 2019, ACEMID operates across Queensland, New South Wales and Victoria, connecting The University of Queensland, Monash University and The University of Sydney with 15 metropolitan, regional, and rural hospitals and health services.
By developing digitally enabled, personalised early detection pathways powered by advanced imaging and AI, ACEMID is transforming the melanoma patient journey — from prevention to diagnosis and treatment. Its integrated, multidisciplinary model ensures the highest research standards and rapid translation into clinical care, setting a new global benchmark for early melanoma and patient outcomes.
Entrant: Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID)

Professor H Peter Soyer, University of Queensland, reviews high-resolution 3D skin images using the 3D imaging system, supporting early melanoma detection through advanced imaging technology.

Professor H Peter Soyer, University of Queensland, takes close-up dermoscopic images to reveal detailed patterns in skin lesions, helping doctors detect melanoma early.
Stay informed
Receive the latest updates about the Shaping Australia Awards program.